Mid-century edit · Free shipping over $85 · Shop teak & mustard
USD22.37 USD51.37

Pay in 4 interest-free payments of $5.59 Learn more

hers semaglutide ban

hers semaglutide ban Hims & stock falls 25% as FDA curtails compounded GLP-1s Ozempic, Wegovy maker calls out

SKU: 7232990895
4.9

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

A Second Lawsuit Complicates the Narrative In the wake of Novo filing suit against Hims, consumer plaintiffs Andrew Donoho and Gloria Ferguson brought a separate case in an Illinois federal court alleging that Hims has misled purchasers by advertising its compounded semaglutide as having the same active ingredient as Ozempic and Wegovy. Unlike Novos patent case, the Illinois complaint does not hinge on whether Hims product contains semaglutide

hers semaglutide ban Hims & stock falls 25% as FDA curtails compounded GLP-1s Ozempic, Wegovy maker calls out

Last updated on Jun 11, 2026

hers semaglutide ban Hims & stock falls 25% as FDA curtails compounded GLP-1s Ozempic, Wegovy maker calls out

Compounding pharmacies, such as The HCG Institute , can prepare customized formulations of semaglutide tailored to individual patient needs

hers semaglutide ban Hims & stock falls 25% as FDA curtails compounded GLP-1s Ozempic, Wegovy maker calls out

95% CI, 1.21 to 66.91

hers semaglutide ban Hims & stock falls 25% as FDA curtails compounded GLP-1s Ozempic, Wegovy maker calls out
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products